We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05404945
Brief Title: Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above

First Submitted : May 22, 2022
First Submitted that Met QC Criteria : May 31, 2022
First Posted : June 3, 2022

Last Update Submitted that Met QC Criteria : July 27, 2022
Last Update Posted : July 29, 2022